The 2nd most cited open-access journal in Clinical Neurology
Neuroepidemiology focuses both on classical neuroepidemiology in robust observational studies, both cross-sectional and longitudinal, and clinical neuroepidemiology in appropriately designed intervention trials, in populations of people with neurological diseases.Read More
The Neuroepidemiology section focuses both on classical neuroepidemiology in robust observational studies, both cross-sectional and longitudinal, and clinical neuroepidemiology in appropriately designed intervention trials, in populations of people with neurological diseases. In highlighting research that identifies and quantitates those risk factors particularly associated with worse health outcomes, and sound translational studies, the research is not simply an academic exercise, but rather aims to develop an evidence base about potentially modifiable factors that can be translated into clinical trials and preventive interventions, ultimately for the benefit of people with these illnesses.
There is thus a particular focus on those neurological diseases where prevention, both primary and secondary, can be a key goal because of the role of modifiable risk factors in their development and progression, particularly lifestyle risk factors. While the evidence base is already robust with considerable clinical translation around some of these diseases such as stroke, other illnesses like multiple sclerosis, Parkinson’s, dementia and systemic diseases with neuroimmune manifestations such as systemic lupus erythematosus will be the focus of this section. An important focus will be on novel and emerging epidemiological methods that more strongly infer causation rather than simply association.
Simple drug intervention trials and industry-sponsored research into drug effectiveness is discouraged, and should be submitted to other sections of the journal where relevant. Independently funded cohort studies reporting real-world surveillance of pharmaceutical agents in neurological disease may however be considered, provided other relevant risk factors associated with health outcomes, particularly lifestyle risk factors, are reported and controlled for.
Neuroepidemiology is committed to developing and strengthening the evidence base around modifiable factors that can be addressed in a preventive medicine model to improve the health outcomes of people with a range of neurological conditions that are currently not considered curable.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, EMBASE, Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Neuroepidemiology welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Clinical Trial, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Systematic Review.
All manuscripts must be submitted directly to the section Neuroepidemiology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Neuroepidemiology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Neurology.